News

AiCure’s Artificial Intelligence Platform Wins 2016 Scrip Award

December 1, 2016

aicure

AiCure, which uses artificial intelligence (AI) on mobile devices to visually confirm medication ingestion, today announced that they are the winners of the 2016 Scrip Award in the category of Best Technological Development in Clinical Trials. Judges from industry, academia, and finance rewarded the artificial intelligence platform for its unique contribution in driving efficiencies and quality data in clinical research. The annual ceremony, which recognizes innovative approaches to drug development, took place in the Grosvenor House Hotel in London’s Mayfair.

Twenty to thirty percent of clinical trials fail because patients do not take the medication according to the protocol, amounting to billions of dollars lost and much-needed drugs not getting to market.

“AiCure is the only clinically-validated and scalable platform to confirm medication ingestion on mobile devices. Changing patient behavior and ensuring accurate data on a dose by dose basis has the potential to transform and streamline the clinical trial process,” said Adam Hanina, CEO and Chairman of AiCure. “We are very grateful to the Scrip judges for recognizing our company as best in class.”

   

Pritzker Group Home Page

Pritzker Group Venture Capital

Pritzker Group Private Capital

Pritzker Group Asset Management